Research & Development
News & Media
Press Releases & Media Coverage
InfanDx AG Reports Successful Validation of Biomarker Panels for the Early Detection of Hypoxic Ischemic Encephalopathy
InfanDx AG Appoints Nicole Witzmann as Chief Financial Officer
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories
Meet InfanDx at these events
No items found.
Get the latest Corporate Presentation
Get a concise overview on our company by downloading our monthly updated Corporate Presentation.
If you would like to receive our press releases and newsletters, please sign up here:
First Name (Required)
Last Name (Required)
Email Address (Required)
I hereby confirm that I want to receive press releases and newsletter from InfanDx AG. I have read and acknowledged InfanDx’
. I understand that I can unsubscribe at anytime by email to
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BioCampus Cologne Geb. S20
InfanDx USA, Inc.
50 Milk Street, 16th Floor
Boston, MA 02110
+49 (0) 221 2927 1401
Fax: +49 (0) 221 2927 1490
© 2022 InfanDx AG | All rights reserved |
HypoxE® is a registered trademark of InfanDx AG